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Background
Placebo-controlled randomised clinical trials on surgical
procedures are rare and there are concerns about the
safety of the placebo arm. The aim of our study was to
analyse the balance between benefits and harms in pla-
cebo-controlled surgical trials.
Methods
We searched MEDLINE, EMBASE, and the Cochrane
Controlled Trials Register, from their beginning to
September 2012, and screened the references of the
already included studies. We reviewed randomised clinical
trials comparing surgery with a placebo intervention. Sur-
gery was defined as any procedure that changes the anat-
omy and requires a skin incision or the use of endoscopic
techniques; dental studies were excluded. We did not limit
the search to any particular type of intervention or
condition.
Results
We reviewed 52 good quality studies. The incidence of
adverse events was higher in the active group and many
of the complications were related to the investigated cri-
tical element of the surgery. Harms directly associated
with the surgical placebo occurred in 4/52 studies, in
13/52 adverse events in the placebo group were related
mainly to the condition and not the intervention, and in
one further trial to both factors. There were no serious
harms arising from the use of a general anaesthetic.
Conclusions
There is a need for more surgical randomised trials with
a placebo arm. Without studies like this there is a risk
of substantially increasing the use of useless and some-
times also harmful procedures. There is a need to
“de-stigmatise” and extend the use of the surgical pla-
cebo in clinical trials.
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